SR

Santbahadur Ramjanam Singh

Active Director Director DIN 08124956
DIN 08124956 First appointment May 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Santbahadur Ramjanam Singh

Data last updated:

Santbahadur Ramjanam Singh is a Director at Curacia Lifesciences Private Limited (since 2018). The company operates in Business Services.

DIN 08124956
Primary Designation Director
Industry Business Services
First Appointment 03 May 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curacia Lifesciences Private Limited U74999MH2018PTC308904
Director03 May 20182018Active

Board colleagues of Santbahadur Ramjanam Singh

Directorship timeline

Open interactive timeline →
Curacia Lifesciences Private Limited
Premium access

Shareholding and investment profile for Santbahadur Ramjanam Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santbahadur Ramjanam Singh

Santbahadur Ramjanam Singh currently holds 1 directorship: Curacia Lifesciences Private Limited (Director, since 03 May 2018).

Santbahadur Ramjanam Singh was first appointed on 03 May 2018 as Director at Curacia Lifesciences Private Limited.

The current boards of Santbahadur Ramjanam Singh's companies include Indersingh Ramsingh Paliwal (Curacia Lifesciences Private Limited), Niraj Harigovind Sinh (Curacia Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available